RecruitingNCT06180551

Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis


Sponsor

Universität des Saarlandes

Enrollment

1,000 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine. Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed. This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients treated on the intensive care units of Saarland University Hospital.

Exclusion Criteria6

  • Patients on renal replacement treatment before admission to the intensive care unit.
  • Patients with chronic kidney disease stage CKD G3b or below.
  • Known kidney disease.
  • Kidney transplantation.
  • Intoxications leading to dialysis treatment.
  • Participation in other clinical trials.

Interventions

DIAGNOSTIC_TESTDKK-3

DKK-3-Urine measurement


Locations(1)

Universitätsklinikum des Saarlandes

Homburg, Saarland, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06180551


Related Trials